The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients
- PMID: 27434539
- PMCID: PMC4951143
- DOI: 10.1371/journal.pone.0159175
The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients
Abstract
Aim: The purpose of the study was the simultaneous measurement of all the different components of the AGE-RAGE axis as well as several non-invasive markers of cardiovascular disease (CVD) in a cohort of newly diagnosed diabetic patients.
Materials and methods: In 80 newly diagnosed diabetic patients we measured serum carboxymethyllysine (CML), soluble RAGE (sRAGE) and peripheral mononuclear (PMNC) RAGE and AGER1 mRNA together with ICAM-1, VCAM-1, and malondialdehyde (MDA). We also assessed cardiovascular function by measurement of flow-mediated vasodilation (FMD), intima-media thickness (IMT) and arterial stiffness. Univariant correlation analysis was used to determine correlation between the variables in the study and multiple regression analysis was used to examine the association between the AGE-RAGE axis components and FMD, IMT and arterial stiffness.
Results: Serum CML correlated positively with sRAGE, PMNC RAGE, HOMA-IR, ICAM-1, VCAM-1 and MDA, but inversely with PMNC AGER1. sRAGE and RAGE was positively correlated with AGER; IMT was positively correlated with HOMA-IR, ICAM-1, VCAM-1, MDA, and sRAGE and arterial stiffness had correlation with HOMA-IR, ICAM-1, VCAM-1, MDA, CML, sRAGE, AGER1 and RAGE. In multivariate analysis we found a significant relationship between CML with PMNC RAGE, HOMA-IR; sRAGE with VCAM-1 and MDA; PMNC RAGE with PMNC AGER1and CML; PMNC AGER1 with PMNC RAGE; FMD with sRAGE, CML and HbA1c; IMT with sRAGE, and arterial stiffness with sRAGE, sCML and AGER1.
Conclusions: We found significant and strong associations between the different components of the AGE-RAGE axis and also found significant association between AGE-RAGE axis markers, especially sRAGE with several noninvasive markers of cardiovascular disease risk. sRAGE, an easily measured parameter in blood, may potentially be used as a surrogate marker of AGEs-RAGE in patients with diabetes.
Conflict of interest statement
Figures


Similar articles
-
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.Cardiovasc Diabetol. 2015 Sep 25;14:126. doi: 10.1186/s12933-015-0292-2. Cardiovasc Diabetol. 2015. PMID: 26408307 Free PMC article.
-
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.Atherosclerosis. 2009 May;204(1):288-92. doi: 10.1016/j.atherosclerosis.2008.08.026. Epub 2008 Sep 2. Atherosclerosis. 2009. PMID: 18926539
-
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.Atherosclerosis. 2012 Jan;220(1):208-14. doi: 10.1016/j.atherosclerosis.2011.07.115. Epub 2011 Aug 5. Atherosclerosis. 2012. PMID: 21906738
-
Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?Int J Angiol. 2017 Mar;26(1):1-11. doi: 10.1055/s-0037-1598183. Epub 2017 Feb 3. Int J Angiol. 2017. PMID: 28255209 Free PMC article. Review.
-
AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.Int J Angiol. 2018 Mar;27(1):1-12. doi: 10.1055/s-0037-1613678. Epub 2017 Dec 28. Int J Angiol. 2018. PMID: 29483760 Free PMC article. Review.
Cited by
-
The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration.Med Sci Monit. 2018 Jan 10;24:190-199. doi: 10.12659/msm.905311. Med Sci Monit. 2018. PMID: 29317590 Free PMC article.
-
Soluble RAGE and skeletal muscle tissue RAGE expression profiles in lean and obese young adults across differential aerobic exercise intensities.J Appl Physiol (1985). 2023 Oct 1;135(4):849-862. doi: 10.1152/japplphysiol.00748.2022. Epub 2023 Sep 7. J Appl Physiol (1985). 2023. PMID: 37675469 Free PMC article.
-
Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis.J Clin Res Pediatr Endocrinol. 2020 Jun 3;12(2):160-167. doi: 10.4274/jcrpe.galenos.2019.2019.0076. Epub 2019 Sep 13. J Clin Res Pediatr Endocrinol. 2020. PMID: 31514489 Free PMC article.
-
The Advanced Glycation End-Products (AGE)-Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases.Int J Mol Sci. 2025 Apr 14;26(8):3707. doi: 10.3390/ijms26083707. Int J Mol Sci. 2025. PMID: 40332316 Free PMC article. Review.
-
The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.Mol Med. 2018 Nov 23;24(1):59. doi: 10.1186/s10020-018-0060-3. Mol Med. 2018. PMID: 30470170 Free PMC article. Review.
References
-
- Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet‐Derived Advanced Glycation End Products Are Major Contributors to the Body’s AGE Pool and Induce Inflammation in Healthy Subjects. Ann NY Acad Sci 2005;1043:461‐466. - PubMed
-
- Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ, Tan KC. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes. Clin Sci (Lond) 2011;120:81–89. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous